News
Barchart on MSN14h
A $1.3 Billion Reason to Buy Eli Lilly Stock NowEli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.
Zacks Investment Research on MSN19h
LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback